期刊文献+

1例溃疡性结肠炎的循证治疗 被引量:1

Evidence-Based Treatment for a Patient with Ulcerative Colitis
下载PDF
导出
摘要 目的针对近期收治的1例常规治疗疗效不理想的溃疡性结肠炎患者,我们进行了证据检索和评价,以期找到更有效的治疗方法。方法计算机检索MEDLINE(1978~2004)、CBMdisc(1978~2004)及Cochrane图书馆(2004年第3期),查找5氨基水杨酸(5ASA)灌肠液治疗溃疡性结肠炎及与病情缓解有关的系统评价、临床随机对照试验等,并对所获证据进行评价。结果高质量的临床证据表明,5ASA灌肠液治疗溃疡性结肠炎及帮助病情缓解均优于口服5ASA及柳氮磺胺嘧啶局部灌肠治疗。据此临床证据,结合医生经验及病人意愿,对该例患者实施5ASA1g+生理盐水100mlqd,睡前保留灌肠治疗。1周后,患者临床症状明显缓解,腹泻基本停止,每天解黄色黏液便1~2次。肠镜复查,炎症较前明显减轻。出院后继续用上述方案维持治疗,每周2次。门诊随访1年,患者未再复发,也无明显副作用发生。结论5ASA灌肠液是控制溃疡性结肠炎活动期间病情及帮助缓解、减少复发的有效药物。 Objective To find the most effective treatment for a patient of ulcerative colitis whose therapeutic effect was not ideal by EBM practice. Methods We attempted to get the evidence of 5-amnnosalicylic acid enemas which was used to treat ulcerative colitis and maintain remission by searching MEDLINE(19782004)、CBMdisc(19782004) and The Cochrane Library(Issue 3, 2004) and the critical appraised evidence. Results We found that 5-amnnosalicylic acid enemas was more effective and better tolerated than oral 5-amnnosalicylic acid and topical sulfalazine in the treatment of ulcerative colitis confined to the distal colon. With the physicians' experiences and patients' preferences, we established a reasonable treatment protocol of enemas with 1 g 5-ASA added to the 100ml sodium chloride, qd. After one week, all the patient's symptoms were improved: Diarrhea relieved, and stool frequency decreased to 12 times per day. The colonoscopy showed that the inflammation was alleviated dramatically. The patient continued the same treatment after discharge. One year follow up showed that the symptoms of the patient did not relapse and there was no serious side effect of 5-ASA. Conclusion 5-aminosalicyclic acid enema is effective, well tolerated in the treatment of ulcerative colitis.
出处 《中国循证医学杂志》 CSCD 2005年第7期571-573,共3页 Chinese Journal of Evidence-based Medicine
关键词 溃疡性结肠炎 5-氨基水杨酸 循证治疗 副作用 Ulcerative colitis 5-aminosalicyclic acid enemas Evidence-based treatment Side-effects
  • 相关文献

参考文献17

  • 1Lloyd RS, Francois M, Scott G, Malcolm R, Norton G, Fred S, Thomas M, Joseph S, Ed Prokipchuk, Lowell B. 5-aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis and proctitis[J]. Gastroenterology, 1987; 92(35): 1894-1898. 被引量:1
  • 2Cobden I, al-Mardini H, Zaitoun A, Record CO. Is topical therapy necessary in acute distal colitis? Double-bind comparison of high-dose oral mesalazine versus steroid enemas in the treatment of active distal ulcerative colitis[J]. Aliment Pharmacol Ther, 1991; 5(5): 513-522. 被引量:1
  • 3Lori K, Hartley C, Cornelius D, Peter R, John Orchard. A comparison of mesalamine suspention enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults[J]. The American Journal of Gastroenterology, 1995; 90(5): 736-739. 被引量:1
  • 4Bianchi PG, Ardizzone S, Petrillo M, Fasoli A, Molteni P, Imbesi V. Low pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis: a randomized, double-blind study[J]. The American Journal of Gastroenterology, 1995; 90(5): 736-739. 被引量:1
  • 5Campieri M, Lanfranchi GA, Bazzocchi G, Brignola C, Sarti F, Franzin G, Battocchia A, Labo G, Dal MontePR. Treatment of ulcerative colitis with high-dose 5-aminosalicyclic acid enemas[J]. Lancet, 1981; 45(8): 270-271. 被引量:1
  • 6Mulder CJ, Tytgat GN, Wiltink EH, Houthoff HJ. Comparison of 5-aminosalicyclic acids and prednisolone phosphate sodium enema in the treatment of distal ulcerative colitis. A prosective, randomized, double-blind trial[J]. Scandinavian Journal of Gastroenterology, 1988; 23(8): 1005-1008. 被引量:1
  • 7Gionhetti P, Ardizzine S, Benvenuti ME. A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicenter trial[J]. Aliment Phamacol Ther, 1999; 13(3): 381-388. 被引量:1
  • 8Danish 5-ASA Group. Topical 5-aminoalicyclic acid versus prednisolone in ulcerative proctosigmoiditis. A randomized double blind multicenter trial[J]. Dig Dis Sci, 1987; 32(6): 598-602. 被引量:1
  • 9Campieri M, Gionchetti P, Benizzi A, Brigola C, Tampieri M, Lannone P, Miglioli M, Barbara L. Optimun dosage of 5-aminoalicyclic acid as rectal enemas in patient with active ulcerative colitis[J]. Gut,1991;32(8):929-931. 被引量:1
  • 10Sutherland L, Macdonald JK. Oral 5-aminoalicyclic acid for induction of remission in ulcerative colitis(Cochrane Review)[M/CD]. In: The Cochrane Library, Issue 3, 2004. Oxford: Update Software. 被引量:1

同被引文献22

  • 1Domenech E. Inflammatory bowel disease:current therapeutic options[ J]. Digestion,2006,73 ( Suppl 1 ) :S67-S76. 被引量:1
  • 2Kim H,Kim D,Choi D,et al. Synthesis and properties of N,N'-bis (5-aminosalicyl)-L-cystine as a colon-specific deliverer of 5-aminosalicylic acid and cystine [J]. Drug Deliv,2008,15 ( 1 ) :37 - 42. 被引量:1
  • 3ung YJ, Lee JS, Kim YM. Colon-specific prodrugs of 5-aminosalicylie acid:synthesis and in vitro/in vivo properties of acidic amino acid derivatives of 5-aminosalicylic acid [ J ]. J Pharm Sci, 2001,90 (11) :1767 -75. 被引量:1
  • 4Karagozian R, Burakoff R. The role of mesalamine in the treatment of ulcerative colitis [J]. Ther Clin Risk Manag, 2007,3 ( 5 ) : 893 - 903. 被引量:1
  • 5Sandborn WJ. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention [ J ]. Rev Gastroenterol Disord ,2006,6 (2) :97 - 105. 被引量:1
  • 6Lichtenstein GR, Kamm MA, Boddu P, et al. Effect of onceor twicedaily MMX mesalamine ( SPD476 ) for the induction of remission of mild to moderately active ulcerative colitis [ J ]. Clin Gastroenterol Hepatol,2007,5 ( 1 ) :95 - 102. 被引量:1
  • 7Kamm MA, Lichtenstein GR, Sandbom WJ, et al. Randomised trial of once-or twice-daily MMX mesalazine ormaintenance of remission in ulcerative colitis[J]. Gut ,2008,57 (7) :893 -902. 被引量:1
  • 8Layer PH, Goebell H, Keller J, etal. Delivery and fate of oral mesalamine microgranules within the human small intestine[J]. Gastroenterology, 1995,108 ( 5 ) : 1427 - 33. 被引量:1
  • 9Rubinstein A. Approaches and opportunities in colon-specific drug delivery[ J]. Crit Rev Ther Drug Carrier Syst, 1995,12:101 -149. 被引量:1
  • 10Yang L,Chu J S,Fix J A. Colon-specific drug delivery:new approaches and in vitro/in vivo evaluation [J]. Int J Pharm,2002,235 : 1 - 15. 被引量:1

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部